NCT00242554View on ClinicalTrials.gov

Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

July 31, 2007

Conditions
Prostate Cancer
Interventions
DRUG

Zoledronic acid

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY